Dubai, UAE: The UAE has become the first country in the world to approve an innovative oral treatment for vitiligo, marking a significant development in the availability of new therapies for the skin condition. The announcement was made at the 10th Emirates Dermatology Conference, which opened in Dubai on 6 November 2026.
The three-day conference, held at the InterContinental Dubai – Festival City, has brought together more than 500 physicians and specialists to explore developments in dermatology, including artificial intelligence, clinical imaging and emerging treatment approaches.
Dr. Ayman Alnaeem, President of the Emirates Dermatology Society and President of the Conference, said that “Building on the success of previous editions, the Emirates Dermatology Conference 2026 brings together a distinguished group of dermatologists, researchers, experts, and industry leaders from across the region and the world, on a specialized scientific platform aimed at enhancing knowledge exchange and advancing medical practice.”
Click here to join our WhatsApp channel here
The scientific programme covers skin ageing, eczema, acne, skin cancer, infectious and inflammatory skin diseases, laser treatments and aesthetic medicine. It also features practical workshops, live demonstrations and interactive clinical sessions, alongside the fifth edition of the Residents’ Academy, which supports the training of future dermatology specialists.
The conference will also feature the launch of the newly approved vitiligo treatment and introduce other emerging therapies, including advanced biological treatments for psoriasis.
Dr. Jawaher Al Naqbi, Head of Dubai’s Bid to Host the World Congress of Dermatology, said “Dubai has submitted an official bid to host the city-level event in 2031, noting that five global cities are competing strongly to host the event, including Madrid, Istanbul, and Cairo. She affirmed that Dubai’s chances are very high given its status and distinguished infrastructure.”
